A case of vincristine-induced polyneuropathy in an patient with acute leukemia.
- Author:
Su Young BACK
1
;
Byeong Bae PARK
;
Dong Won PARK
;
Joo Hyoung KIM
;
Kyong Hee JUNG
;
Hye Young KIM
;
So Yeon PARK
Author Information
1. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. bbpark@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Vincristine;
Neurotoxicity;
Polyneuropathy
- MeSH:
Adolescent;
Cranial Nerve Diseases;
Diagnosis, Differential;
Drug Toxicity;
Humans;
Induction Chemotherapy;
Leukemia;
Leukemic Infiltration;
Nervous System;
Nervous System Diseases;
Polyneuropathies;
Precursor Cell Lymphoblastic Leukemia-Lymphoma;
Vincristine
- From:Korean Journal of Medicine
2009;76(5):611-616
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
When neurological symptoms occur during the treatment of acute lymphoblastic leukemia, the differential diagnosis includes a leukemic infiltration of the nervous system, drug toxicity, infection, and other neurological disorders. We describe a 16-year-old girl with acute lymphoblastic leukemia that appeared to be complicated by vincristine-induced peripheral and cranial polyneuropathy after induction chemotherapy. She presented with right ptosis six weeks after the first dose of vincristine, and her neurological symptoms progressed to peripheral polyneuropathy. She recovered from these neurological symptoms over the next three months. Leukemic involvement of the nervous system and other neurological disorders could be excluded as potential causes of the neurological symptoms. This report shows that vincristine-induced neurotoxicity should be considered as a cause of cranial neuropathy that develops during the treatment of acute lymphoblastic leukemia.
